SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Vitae Pharmaceuticals, Inc. Announces Promising Data for VTP-4, Drug Candidate Advancing Toward Clinical Testing for the Treatment of Atherosclerosis